Education
About Us
Working with TipRanks
Follow Us
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
Total Valuation
XORTX Therapeutics Inc has a market cap or net worth of $3.07M. The enterprise value is $537.31K.
Market Cap$3.07M
Enterprise Value$537.31K
Share Statistics
XORTX Therapeutics Inc has 6,962,218 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,962,218
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
XORTX Therapeutics Inc’s return on equity (ROE) is -1.30 and return on invested capital (ROIC) is -156.43%.
Return on Equity (ROE)-1.30
Return on Assets (ROA)-1.01
Return on Invested Capital (ROIC)-156.43%
Return on Capital Employed (ROCE)-1.59
Revenue Per Employee0.00
Profits Per Employee-1.86M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XORTX Therapeutics Inc is ―. XORTX Therapeutics Inc’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio1.28
Price to Fair Value1.28
Price to FCF-0.94
Price to Operating Cash Flow-0.95
PEG Ratio0.02
Income Statement
In the last 12 months, XORTX Therapeutics Inc had revenue of 0.00 and earned -3.71M in profits. Earnings per share was -0.78.
Revenue0.00
Gross Profit-156.66K
Operating Income-4.55M
Pretax Income-3.71M
Net Income-3.71M
EBITDA-4.39M
Earnings Per Share (EPS)-0.78
Cash Flow
In the last 12 months, operating cash flow was -3.04M and capital expenditures -25.21K, giving a free cash flow of -3.06M billion.
Operating Cash Flow-3.04M
Free Cash Flow-3.06M
Free Cash Flow per Share-0.44
Dividends & Yields
XORTX Therapeutics Inc pays an annual dividend of $0.075, resulting in a dividend yield of ―
Dividend Per Share$0.075
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change-51.85%
50-Day Moving Average0.50
200-Day Moving Average0.71
Relative Strength Index (RSI)56.05
Average Volume (3m)3.79M
Important Dates
XORTX Therapeutics Inc upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 15, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
XORTX Therapeutics Inc as a current ratio of 1.61, with Debt / Equity ratio of 1.79%
Current Ratio1.61
Quick Ratio1.61
Debt to Market Cap0.01
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, XORTX Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
XORTX Therapeutics Inc EV to EBITDA ratio is -0.57, with an EV/FCF ratio of -0.65.
EV to Sales0.00
EV to EBITDA-0.57
EV to Free Cash Flow-0.65
EV to Operating Cash Flow-0.65
Balance Sheet
XORTX Therapeutics Inc has $1.19M in cash and marketable securities with $51.11K in debt, giving a net cash position of $1.13M billion.
Cash & Marketable Securities$1.19M
Total Debt$51.11K
Net Cash$1.13M
Net Cash Per Share$0.16
Tangible Book Value Per Share$0.55
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XORTX Therapeutics Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―